Ligand Pharmaceuticals
LGND
LGND
293 hedge funds and large institutions have $3.35B invested in Ligand Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 114 increasing their positions, 81 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
293
Holders Change
+28
Holders Change %
+10.57%
% of All Funds
7.32%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.25%
New
52
Increased
114
Reduced
81
Closed
20
Calls
$11.2M
Puts
$19.3M
Net Calls
-$8.01M
Net Calls Change
-$29.2M
Top Buyers
1 |
Bank of America
Charlotte,
North Carolina
|
+$57.7M |
2 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$42.5M |
3 |
BlackRock
New York
|
+$35.6M |
4 |
Janus Henderson Group
London,
United Kingdom
|
+$21.7M |
5 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$17.8M |